ICH M10 draft [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2019-03-13 18:06 (555 d 15:35 ago) – Posting: # 20023
Views: 3,086

Dear all,

"New or Alternative Technologies" an interesting part in the newly issued draft of BIOANALYTICAL METHOD VALIDATION, ICH M10 which Endorsed on 26 February 2019.

- When a new or alternative technology is used as the sole bioanalytical technology from the onset of drug development, cross-validation with an existing technology is not required.
Cross-validation but required when using two different bioanalytical technologies for the development of a drug.

on the other hand, The use of two methods or technologies within a
comparative BA/BE study is strongly discouraged:. (i.e not applicable at all also with cross-validation).:confused::confused:
Why ??

Best regards,
Osama


Edit: Post moved. [Helmut]

Cheers,
Osama

Complete thread:

Activity
 Admin contact
21,068 posts in 4,392 threads, 1,466 registered users;
online 18 (0 registered, 18 guests [including 7 identified bots]).
Forum time: Saturday 10:42 CEST (Europe/Vienna)

The purpose of models is not to fit the data,
but to sharpen the questions.    Samuel Karlin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5